716 results on '"Howitt, Brooke E."'
Search Results
52. Clinicopathological and immunohistochemical features of uterine adenomyomatous polyps
53. From morphology to methylome: epigenetic studies of Müllerian mesonephric‐like adenocarcinoma reveal similarities to cervical mesonephric adenocarcinoma†.
54. A Clinical and Pathologic Exploration of Suspected Peritoneal Endometriotic Lesions
55. Specific Pathology Features Enrich Selection of Endometrial Carcinomas for POLE Testing
56. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024
57. FIGO 2023 endometrial cancer staging: too much, too soon?
58. SMARCA4 loss irrelevant for ARID1A mutated ovarian clear cell carcinoma: a case report
59. Epithelial Malignant Tumors of the Cervix: Neuroendocrine Tumors
60. Molecular Pathology of Uterine Mesenchymal Tumors
61. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma
62. Inter-pathologist and pathology report agreement for ovarian tumor characteristics in the Nurses' Health Studies
63. Mesonephric proliferations of the female genital tract
64. Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract: A Multi-institutional Study
65. Clinical Behavior and Molecular Landscape of Stage I p53-abnormal Low-Grade Endometrioid Endometrial Carcinomas
66. Frequency of “incidental” serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: A six-year study
67. Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer
68. Sentinel lymph node mapping reduces practice pattern variations in surgical staging for endometrial adenocarcinoma: A before and after study
69. Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA
70. FIGO 2023 endometrial cancer staging: too much, too soon?
71. Clinical Features of SARS-CoV-2 Infection During Pregnancy and Associated Placental Pathologies.
72. Molecular Characterization of Neuroendocrine Carcinomas of the Endometrium: Representation in All 4 TCGA Groups
73. Clinicopathologic and Immunohistochemical Correlates of CTNNB1 Mutated Endometrial Endometrioid Carcinoma
74. SMARCA4-deficient Uterine Sarcoma and Undifferentiated Endometrial Carcinoma Are Distinct Clinicopathologic Entities
75. Genomic Characterization of HPV-related and Gastric-type Endocervical Adenocarcinoma: Correlation With Subtype and Clinical Behavior
76. Reasons Associated with Total Thyroidectomy as Initial Surgical Management of an Indeterminate Thyroid Nodule
77. Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
78. Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
79. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Uterine Tumors
80. Pattern-based classification of invasive endocervical adenocarcinoma, depth of invasion measurement and distinction from adenocarcinoma in situ: interobserver variation among gynecologic pathologists
81. Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas
82. Targeted Genomic Profiling of Female Adnexal Tumors of Probable Wolffian Origin (FATWO)
83. Evidence of a Monoclonal Origin for Bilateral Serous Tubal Intraepithelial Neoplasia
84. HPV 6-associated HSIL/Squamous Carcinoma in the Anogenital Tract
85. Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC)
86. A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the Endometrium
87. International Endocervical Adenocarcinoma Criteria and Classification: Validation and Interobserver Reproducibility
88. Adenocarcinoma, Carcinosarcoma, and Other Epithelial Tumors of the Endometrium
89. Preface
90. Uterine Mesenchymal Tumors
91. Dedication
92. Contributors
93. The Pathology of Pelvic-Ovarian Epithelial (Epithelial-Stromal) Tumors
94. Supplemental Table 3 from A BRCA1/2 Mutational Signature and Survival in Ovarian High-Grade Serous Carcinoma
95. Supplementary Table S2 from Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity
96. Supplementary Fig. S1 from Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity
97. Data from A BRCA1/2 Mutational Signature and Survival in Ovarian High-Grade Serous Carcinoma
98. Supplemental Table 1 from A BRCA1/2 Mutational Signature and Survival in Ovarian High-Grade Serous Carcinoma
99. Supplementary Material and Methods from Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity
100. Supplemental Table 2 from A BRCA1/2 Mutational Signature and Survival in Ovarian High-Grade Serous Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.